Physician profile
Eric D Johnson
NPI 1972914349
$3,333.65
in general payments reported to CMS, 2019-2025
17 companies · $996 in 2025
The $996 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $99.56 · 2023: $1,079 · 2024: $971 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,884 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,883.76 |
| Education | $162.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,165.06 | 2023-2025 | |
| Harmony Biosciences LLC | $784.64 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $574.65 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $127.22 | 2024-2025 | Quviviq, Quviviq |
| Shockwave Medical, INC | $107.23 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Avadel Cns Pharmaceuticals, LLC | $98.06 | 2024-2025 | Lumryz |
| E.R. Squibb & Sons, L.L.C. | $83.25 | 2023 | |
| Inspire Medical Systems, INC. | $77.98 | 2024-2025 | Inspire |
| Medtronic, INC. | $70.61 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $67.92 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.09 | 2021-2022 | |
| Abbott Laboratories | $45.48 | 2022 | |
| Resmed Corp | $20.15 | 2025 | |
| Sobi, INC | $18.78 | 2022 | |
| Boston Scientific Corporation | $15.90 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $15.21 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.42 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.